A study published on September 6, 2026, indicates that psilocybin may be effective in preventing chemotherapy-induced peripheral neuropathy, a painful side effect for cancer patients.
Researchers observed that controlled doses of the psychedelic compound helped protect nerve cells in mouse models, suggesting a potential new therapeutic pathway for cancer treatment.
While clinical trials are still required, the findings offer hope for managing long-term nerve damage, which currently affects a significant percentage of patients undergoing standard chemotherapy.